These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 32336416)
1. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics. Sapienza MR; Pileri S Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416 [TBL] [Abstract][Full Text] [Related]
2. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective. Hirner JP; O'Malley JT; LeBoeuf NR Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415 [TBL] [Abstract][Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report. Dang X; Zhou D; Meng L; Bi L J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792 [TBL] [Abstract][Full Text] [Related]
4. Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm. Lane AA Hematol Oncol Clin North Am; 2020 Jun; 34(3):589-600. PubMed ID: 32336422 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis of 46 cases with CD4 Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm. Kharfan-Dabaja MA; Cherry M Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [TBL] [Abstract][Full Text] [Related]
9. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y; Yang J; Lindsey K Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations. Sakamoto K; Takeuchi K Hematol Oncol Clin North Am; 2020 Jun; 34(3):523-538. PubMed ID: 32336417 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm. Xue T; Budde LE Hematol Oncol Clin North Am; 2020 Jun; 34(3):575-587. PubMed ID: 32336421 [TBL] [Abstract][Full Text] [Related]
13. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]
14. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444 [TBL] [Abstract][Full Text] [Related]
15. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364 [TBL] [Abstract][Full Text] [Related]
17. Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN. Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA Curr Hematol Malig Rep; 2017 Dec; 12(6):592-597. PubMed ID: 29064025 [TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126 [TBL] [Abstract][Full Text] [Related]
19. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective. Deconinck E Hematol Oncol Clin North Am; 2020 Jun; 34(3):613-620. PubMed ID: 32336424 [TBL] [Abstract][Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]